China Nagano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
China Nagano has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Hiroki Kondou
Department of Pediatrics Kindai University Nara Hospital Nara Japan
1 shared publication - Keisuke Sugimoto
Kindai University Faculty of Medicine
1 shared publication - Kensuke Joh
Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan
1 shared publication - Kohei Miyazaki
Kindai University Faculty of Medicine Hospital: Kinki Daigaku Igakubu Daigaku Byoin
1 shared publication - Masaaki Miyazawa
Department of Immunology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan
1 shared publication - Naoaki Sakata
Kindai University Faculty of Medicine, Osakasayama, Japan
1 shared publication
Latest Publications
- Open Access
- 31 October 2023
- Published by Springer Nature in Research Square
Potentially protein-destabilizing C3 polymorphism in a case of atypical hemolytic uremic syndrome with life-threatening extrarenal manifestations
Background: Atypical hemolytic uremic syndrome (aHUS) is a rare, life-threatening disease caused by uncontrolled complement activation. It is frequently associated with a genetic factor including various polymorphisms at the C3 gene locus; however, no functional amino acid substitution in the C-terminal domain has been reported. We experienced a pediatric case of aHUS with multisystem involvements including refractory hypertension and gastrointestinal bleeding in which immunohistochemical, genetic, and molecular structural analyses were performed. Methods: Biopsy specimens were stained for renin and C5b-9. Serum factor Ba levels were measured to evaluate the alternative pathway activation. Genomic DNA was obtained with consent for targeted Sanger sequencing. The possible effects of the identified amino acid substitution on the molecular structure of C3 were analyzed by computer-aided simulation. Results: Immunostaining revealed intense renin staining in the hyperplastic juxtaglomerular apparatus. Endothelial cells of renal and intestinal blood vessels were positive for C5b-9. Serum Ba level in the active phase was higher than control level. Genetic analyses showed a C3 polymorphism resulting in M1604T substitution in the C345C domain. Although previously reported to be a variant of unknown significance, molecular structural analysis indicated that this amino acid substitution results in the formation of a large space within the hydrophobic core of the C-terminal domain, possibly destabilizing the spherical structure of C3. Renin-angiotensin system inhibitors for refractory hypertension were effective in this patient. Conclusions: M1604T substitution in the C345C domain of C3 molecule may functionally underlie the observed life-threatening extrarenal manifestations.
- 31 October 2023
- Published by Springer Nature in Research Square
Open AccessPotentially protein-destabilizing C3 polymorphism in a case of atypical hemolytic uremic syndrome with life-threatening extrarenal manifestations
Background: Atypical hemolytic uremic syndrome (aHUS) is a rare, life-threatening disease caused by uncontrolled complement activation. It is frequently associated with a genetic factor including various polymorphisms at the C3 gene locus; however, no functional amino acid substitution in the C-terminal domain has been reported. We experienced a pediatric case of aHUS with multisystem involvements including refractory hypertension and gastrointestinal bleeding in which immunohistochemical, genetic, and molecular structural analyses were performed. Methods: Biopsy specimens were stained for renin and C5b-9. Serum factor Ba levels were measured to evaluate the alternative pathway activation. Genomic DNA was obtained with consent for targeted Sanger sequencing. The possible effects of the identified amino acid substitution on the molecular structure of C3 were analyzed by computer-aided simulation. Results: Immunostaining revealed intense renin staining in the hyperplastic juxtaglomerular apparatus. Endothelial cells of renal and intestinal blood vessels were positive for C5b-9. Serum Ba level in the active phase was higher than control level. Genetic analyses showed a C3 polymorphism resulting in M1604T substitution in the C345C domain. Although previously reported to be a variant of unknown significance, molecular structural analysis indicated that this amino acid substitution results in the formation of a large space within the hydrophobic core of the C-terminal domain, possibly destabilizing the spherical structure of C3. Renin-angiotensin system inhibitors for refractory hypertension were effective in this patient. Conclusions: M1604T substitution in the C345C domain of C3 molecule may functionally underlie the observed life-threatening extrarenal manifestations.